Antibiotic resistance and typhoid

Zoe A. Dyson, Elizabeth J. Klemm, Sophie Palmer, Gordon Dougan

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Multiple drug (antibiotic) resistance (MDR) has become a major threat to the treatment of typhoid and other infectious diseases. Since the 1970s, this threat has increased in Salmonella enterica serovar Typhi, driven in part by the emergence of successful genetic clades, such as haplotype H58, associated with the MDR phenotype. H58 S. Typhi can express multiple antibiotic resistance determinants while retaining the ability to efficiently transmit and persist within the human population. The recent identification of extensively drug resistant S. Typhi only highlights the dangers of ignoring this threat. Here we discuss the evolution of the S. Typhi MDR phenotype and consider options for management.

Original languageEnglish
Pages (from-to)S165-S170
Number of pages6
JournalClinical Infectious Diseases
Volume68
DOIs
Publication statusPublished - 7 Mar 2019
Externally publishedYes

Keywords

  • H58
  • MDR
  • multiple drug resistance
  • S. Typhi
  • typhoid

Cite this

Dyson, Zoe A. ; Klemm, Elizabeth J. ; Palmer, Sophie ; Dougan, Gordon. / Antibiotic resistance and typhoid. In: Clinical Infectious Diseases. 2019 ; Vol. 68. pp. S165-S170.
@article{8cb41d1ee371400c9eb235378b31e8a7,
title = "Antibiotic resistance and typhoid",
abstract = "Multiple drug (antibiotic) resistance (MDR) has become a major threat to the treatment of typhoid and other infectious diseases. Since the 1970s, this threat has increased in Salmonella enterica serovar Typhi, driven in part by the emergence of successful genetic clades, such as haplotype H58, associated with the MDR phenotype. H58 S. Typhi can express multiple antibiotic resistance determinants while retaining the ability to efficiently transmit and persist within the human population. The recent identification of extensively drug resistant S. Typhi only highlights the dangers of ignoring this threat. Here we discuss the evolution of the S. Typhi MDR phenotype and consider options for management.",
keywords = "H58, MDR, multiple drug resistance, S. Typhi, typhoid",
author = "Dyson, {Zoe A.} and Klemm, {Elizabeth J.} and Sophie Palmer and Gordon Dougan",
year = "2019",
month = "3",
day = "7",
doi = "10.1093/cid/ciy1111",
language = "English",
volume = "68",
pages = "S165--S170",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",

}

Antibiotic resistance and typhoid. / Dyson, Zoe A.; Klemm, Elizabeth J.; Palmer, Sophie; Dougan, Gordon.

In: Clinical Infectious Diseases, Vol. 68, 07.03.2019, p. S165-S170.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Antibiotic resistance and typhoid

AU - Dyson, Zoe A.

AU - Klemm, Elizabeth J.

AU - Palmer, Sophie

AU - Dougan, Gordon

PY - 2019/3/7

Y1 - 2019/3/7

N2 - Multiple drug (antibiotic) resistance (MDR) has become a major threat to the treatment of typhoid and other infectious diseases. Since the 1970s, this threat has increased in Salmonella enterica serovar Typhi, driven in part by the emergence of successful genetic clades, such as haplotype H58, associated with the MDR phenotype. H58 S. Typhi can express multiple antibiotic resistance determinants while retaining the ability to efficiently transmit and persist within the human population. The recent identification of extensively drug resistant S. Typhi only highlights the dangers of ignoring this threat. Here we discuss the evolution of the S. Typhi MDR phenotype and consider options for management.

AB - Multiple drug (antibiotic) resistance (MDR) has become a major threat to the treatment of typhoid and other infectious diseases. Since the 1970s, this threat has increased in Salmonella enterica serovar Typhi, driven in part by the emergence of successful genetic clades, such as haplotype H58, associated with the MDR phenotype. H58 S. Typhi can express multiple antibiotic resistance determinants while retaining the ability to efficiently transmit and persist within the human population. The recent identification of extensively drug resistant S. Typhi only highlights the dangers of ignoring this threat. Here we discuss the evolution of the S. Typhi MDR phenotype and consider options for management.

KW - H58

KW - MDR

KW - multiple drug resistance

KW - S. Typhi

KW - typhoid

UR - http://www.scopus.com/inward/record.url?scp=85062644364&partnerID=8YFLogxK

U2 - 10.1093/cid/ciy1111

DO - 10.1093/cid/ciy1111

M3 - Article

VL - 68

SP - S165-S170

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

ER -